Beam Therapeutics Inc. financial data

Symbol
BEAM on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
26 Landsdowne Street, Cambridge, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 557 % +13.4%
Debt-to-equity 52.3 % -33%
Return On Equity -16.2 % +62.6%
Return On Assets -10.7 % +56.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 82.4M shares +4.06%
Common Stock, Shares, Outstanding 82.4M shares +5.69%
Entity Public Float 2.11B USD -14.2%
Common Stock, Value, Issued 824K USD +5.64%
Weighted Average Number of Shares Outstanding, Basic 82.3M shares +7.83%
Weighted Average Number of Shares Outstanding, Diluted 82.3M shares +7.83%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 353M USD +340%
Research and Development Expense 412M USD +11.7%
General and Administrative Expense 125M USD +34.9%
Operating Income (Loss) -184M USD +51.6%
Nonoperating Income (Expense) 42.8M USD -48.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -91M USD -9.95%
Income Tax Expense (Benefit) 1.41M USD -58.8%
Net Income (Loss) Attributable to Parent -143M USD +56.3%
Earnings Per Share, Basic -1.63 USD/shares +63.9%
Earnings Per Share, Diluted -1.63 USD/shares +63.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 293M USD +29.8%
Marketable Securities, Current 715M USD -15.6%
Cash, Cash Equivalents, and Short-term Investments 1B USD -9.09%
Assets, Current 1.03B USD -5.97%
Property, Plant and Equipment, Net 117M USD -8.37%
Operating Lease, Right-of-Use Asset 107M USD -6.31%
Other Assets, Noncurrent 1.32M USD -4.27%
Assets 1.26B USD -6.84%
Accounts Payable, Current 4.43M USD -35.7%
Employee-related Liabilities, Current 9.64M USD -2.95%
Contract with Customer, Liability, Current 84.9M USD -39%
Liabilities, Current 177M USD -15.4%
Contract with Customer, Liability, Noncurrent 75.5M USD -51.7%
Operating Lease, Liability, Noncurrent 153M USD -6.87%
Other Liabilities, Noncurrent 679K USD -43%
Liabilities 407M USD -24.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.11M USD +44.9%
Retained Earnings (Accumulated Deficit) -1.38B USD -11.6%
Stockholders' Equity Attributable to Parent 854M USD +5.23%
Liabilities and Equity 1.26B USD -6.84%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -99.7M USD +9.17%
Net Cash Provided by (Used in) Financing Activities 2.9M USD -97.1%
Net Cash Provided by (Used in) Investing Activities -53.5M USD -310%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 82.4M shares +5.69%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -150M USD -1170%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 299M USD +24%
Interest Paid, Excluding Capitalized Interest, Operating Activities 14K USD -77.4%
Deferred Tax Assets, Valuation Allowance 329M USD +29.5%
Deferred Tax Assets, Gross 366M USD +23.3%
Operating Lease, Liability 173M USD -3.53%
Depreciation 21.6M USD +27.7%
Payments to Acquire Property, Plant, and Equipment 2.44M USD -59.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -142M USD +56.3%
Lessee, Operating Lease, Liability, to be Paid 251M USD -6.22%
Property, Plant and Equipment, Gross 179M USD +6.45%
Operating Lease, Liability, Current 12.6M USD +10%
Lessee, Operating Lease, Liability, to be Paid, Year Two 25.3M USD +3.53%
Lessee, Operating Lease, Liability, to be Paid, Year One 25M USD +15.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 78.6M USD -11.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 22.5M USD -10%
Deferred Tax Assets, Operating Loss Carryforwards 3.96M USD -84.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 23.2M USD +4.21%
Operating Lease, Payments 19.1M USD +66.2%
Additional Paid in Capital 2.23B USD +9%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 5.43M USD +16.9%
Share-based Payment Arrangement, Expense 109M USD +15.2%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%